Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment

A Fabi, R Bhargava, S Fatigoni, M Guglielmo, M Horneber, F Roila, J Weis, K Jordan, C I Ripamonti, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org, A Fabi, R Bhargava, S Fatigoni, M Guglielmo, M Horneber, F Roila, J Weis, K Jordan, C I Ripamonti, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

No abstract available

Keywords: Clinical Practice Guidelines; cancer-related fatigue; diagnosis; treatment.

Conflict of interest statement

Disclosure AF has reported advisory boards and/or honoraria for presentations for Roche, Pfizer, Lilly and Celgene; KJ has reported advisory boards and/or honoraria for presentations for Merck Sharp & Dohme, Merck, Amgen, Hexal, Reimser, Helsinn, Tesaro, Kreussler, Voluntis, Pzifer, Pomme-Med, PharmaMar, Prime Oncology and Onko Update; CIR has reported collaborations with Inpharm, Kyowa Kirin, Amgen Europe and Molteni Spa; RB, FR, SF, JW, MG and MVH have declared no potential conflicts of interest.